SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
Under the Securities Exchange Act of 1934
SCHEDULE 13G
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
IR BIOSCIENCES HOLDINGS, INC.
--------------------
(Name of Issuer)
Common Stock, $.001 par value per share
---------------------------------------
(Title of Class of Securities)
46264M303
------------
(CUSIP Number)
August 25, 2008
------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
Page 1 of 2 Pages
SCHEDULE 13G
CUSIP No. 46264M303 Page 2 of 2 Pages
-------------------------------------------------------------------------------
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
BRENCOURT ADVISORS, LLC EIN # 13-4137530
-------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |X|
-------------------------------------------------------------------------------
3) SEC USE ONLY
-------------------------------------------------------------------------------
4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------------------
5) SOLE VOTING POWER
NUMBER 0
OF --------------------------------------------------
SHARES 6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 1,163,959
EACH --------------------------------------------------
REPORTING 7) SOLE DISPOSITIVE POWER
PERSON
WITH 0
--------------------------------------------------
8) SHARED DISPOSITIVE POWER
1,163,959
-------------------------------------------------------------------------------
9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,163,959
-------------------------------------------------------------------------------
10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|_|
-------------------------------------------------------------------------------
11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.98%
-------------------------------------------------------------------------------
12) TYPE OF REPORTING PERSON
IA
-------------------------------------------------------------------------------
CUSIP No. 46264M303
-------------------------------------------------------------------------------
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Brencourt Multi-Strategy Master, Ltd. EIN # 03-0453123
-------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |X|
-------------------------------------------------------------------------------
3) SEC USE ONLY
-------------------------------------------------------------------------------
4) CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda
-------------------------------------------------------------------------------
5) SOLE VOTING POWER
NUMBER 0
OF --------------------------------------------------
SHARES 6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 500,502
EACH --------------------------------------------------
REPORTING 7) SOLE DISPOSITIVE POWER
PERSON
WITH 0
--------------------------------------------------
8) SHARED DISPOSITIVE POWER
500,502
-------------------------------------------------------------------------------
9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
500,502
-------------------------------------------------------------------------------
10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|_|
-------------------------------------------------------------------------------
11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.29%
-------------------------------------------------------------------------------
12) TYPE OF REPORTING PERSON
CO
-------------------------------------------------------------------------------
CUSIP No. 46264M303
-------------------------------------------------------------------------------
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MAN MAC Schreckhorn 14B Limited EIN #
-------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |X|
-------------------------------------------------------------------------------
3) SEC USE ONLY
-------------------------------------------------------------------------------
4) CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda
-------------------------------------------------------------------------------
5) SOLE VOTING POWER
NUMBER 0
OF --------------------------------------------------
SHARES 6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 651,817
EACH --------------------------------------------------
REPORTING 7) SOLE DISPOSITIVE POWER
PERSON
WITH 0
--------------------------------------------------
8) SHARED DISPOSITIVE POWER
651,817
-------------------------------------------------------------------------------
9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
651,817
-------------------------------------------------------------------------------
10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|_|
-------------------------------------------------------------------------------
11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.59%
-------------------------------------------------------------------------------
12) TYPE OF REPORTING PERSON
CO
-------------------------------------------------------------------------------
CUSIP No. 46264M303
-------------------------------------------------------------------------------
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Brencourt Enhanced Multi-Strategy Dedicated Fund L.P. EIN #
-------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |X|
-------------------------------------------------------------------------------
3) SEC USE ONLY
-------------------------------------------------------------------------------
4) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
-------------------------------------------------------------------------------
5) SOLE VOTING POWER
NUMBER 0
OF --------------------------------------------------
SHARES 6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 11,640
EACH --------------------------------------------------
REPORTING 7) SOLE DISPOSITIVE POWER
PERSON
WITH 0
--------------------------------------------------
8) SHARED DISPOSITIVE POWER
11,640
-------------------------------------------------------------------------------
9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,640
-------------------------------------------------------------------------------
10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|_|
-------------------------------------------------------------------------------
11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.10%
-------------------------------------------------------------------------------
12) TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------------------
Schedule 13G
Item 1(a).
Name of Issuer: IR Biosciences Holdings, INC.
Item 1(b). Address of Issuer's Principal Executive Offices:
8767 E. Via De Ventura, Suite 190
Scottsdale, AZ 85258
Item 2(a). Name of Persons Filing:
Brencourt Advisors, LLC
Brencourt Multi-Strategy Master, Ltd.
MAN MAC Schreckhorn 14B Limited
Brencourt Enhanced Multi-Strategy Dedicated Fund L.P.
Item 2(b). Address of Principal Business Office or, if None, Residence:
The principal office of Brencourt Advisors, LLC is:
600 Lexington Avenue
8th Floor
New York, NY 10022
Item 2(c). Citizenship:
Brencourt Advisors, LLC - Delaware
Brencourt Multi-Strategy Master, Ltd. - Bermuda
MAN MAC Schreckhorn 14B Limited - Bermuda
Brencourt Enhanced Multi-Strategy Dedicated Fund L.P. - Cayman Islands
Item 2(d). Title of Class of Securities:
Common Stock, $0.001 par value per share
Item 2(e). CUSIP Number:
46264M303
Item 3. If this statement is filed pursuant to ss.ss. 240.13d-1(b), or
240.13d-2(b) or (c), check whether the person filing is a:
(a) |_| Broker or Dealer Registered Under Section 15 of the Act
(15 U.S.C. 78o)
(b) |_| Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
78c)
(c) |_| Insurance Company as defined in section 3(a)(19) of the
Act (15 U.S.C. 78c)
(d) |_| Investment Company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8)
(e) |X| Investment Adviser in accordance with ss.
240.13d-1(b)(1)(ii)(E)
(f) |_| Employee benefit plan or endowment fund in accordance with
ss. 240.13d-1(b)(1)(ii)(F)
(g) |_| Parent Holding Company or control person in accordance
with ss.240.13d-1(b)(ii)(G)
(h) |_| Savings Association as defined in ss.3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813)
(i) |_| Church plan that is excluded from the definition of an
investment company under ss.3(c)(15) of the Investment Company
Act of 1940 (15 U.S.C. 80a-3)
(j) |_| Group, in accordance with ss.240.13d-1(b)(ii)(J)
Item 4. Ownership.
(a) Amount beneficially owned: 1,163,959
(b) Percent of class: 9.98%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
1,163,959
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
1,163,959
--------------
(1) Percentages are based on 11,622,916 shares of Common Stock outstanding as of
August 7, 2008 (as set forth on the Issuer's Form 10-Q, filed on August 14,
2008 with the Securities and Exchange Commission).
Item 5. [ ] Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Various persons have the right to receive or the power to direct the receipt
of dividends from, or the proceeds from the sale of, the shares of IR
Biosciences Holdings, Inc. The Investment Manager is the investment advisor
to MAN MAC Schreckhorn 14B Limited. Accordingly, MAN MAC Schreckhorn 14B
Limited has the right to receive and the power to direct receipt of dividends
from, or the proceeds from the sale of, the shares reported in the
corresponding Item 9 above, which represent greater than 5% of the shares
outstanding.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired and are held in the
ordinary course of business and were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having such purpose or effect.
SIGNATURE
----------
After reasonable inquiry and to the best knowledge and belief of
the undersigned, the undersigned certifies that the information set forth in
this Statement is true, complete and correct.
Dated as of August 27, 2008
Brencourt Advisors, LLC
By: Adam Hopkins
Chief Compliance Officer
By: /s/ Adam Hopkins
--------------------------------------